Medindia
Medindia LOGIN REGISTER
Advertisement

Encouraging Preliminary Safety and Efficacy Trends in Phase 2 Clinical Study of PEG-PAL in PKU

Tuesday, August 3, 2010 Hospital News
Advertisement
Conference Call and Webcast to Be Held Today at 5:00 p.m. ET

Contacts:

Investors

Media

Eugenia Shen

Susan Berg

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 506-6570

(415) 506-6594

Sponsored Post and Backlink Submission


Latest Press Release on Hospital News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close